# United Bankshares Inc: overview

UBSI · Nasdaq · CIK 729986 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ubsi.md) · [Financials](/companies/ubsi/financials.md) · [Filings](/companies/ubsi/filings.md) · [Insiders](/companies/ubsi/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.70](/filings/0001193125-26-081470.md) | [0.69](/filings/0001193125-26-081470.md) | [0.59](/filings/0001193125-26-213783.md) | [0.85](/filings/0001193125-26-339565.md) | [0.92](/filings/0001193125-26-081470.md) | [0.91](/filings/0001193125-26-081470.md) | [0.89](/filings/0001193125-26-213783.md) | [0.95](/filings/0001193125-26-339565.md) |
| Free cash flow | $m | [122 d](/filings/0001193125-25-271463.md) | [133 d](/filings/0001193125-26-081470.md) | [116](/filings/0001193125-26-213783.md) | [85.2 d](/filings/0001193125-26-339565.md) | [146 d](/filings/0001193125-25-271463.md) | [133 d](/filings/0001193125-26-081470.md) | [156](/filings/0001193125-26-213783.md) | [98.0 d](/filings/0001193125-26-339565.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [331](/filings/0001193125-23-056045.md) | [312](/filings/0001193125-23-056045.md) | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [111.1%](/filings/0001193125-24-053462.md) | [121.7%](/filings/0001193125-25-042589.md) | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.83](/filings/0001193125-24-053462.md) | [2.80](/filings/0001193125-25-042589.md) | [2.71](/filings/0001193125-26-081470.md) | [2.75](/filings/0001193125-26-081470.md) | [3.27](/filings/0001193125-26-081470.md) |
| Free cash flow | $m | [594](/filings/0001193125-24-053462.md) | [744](/filings/0001193125-25-042589.md) | [424](/filings/0001193125-26-081470.md) | [433](/filings/0001193125-26-081470.md) | [481](/filings/0001193125-26-081470.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ubsi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $925.2m | 20,187,911 |  | Added +21,373 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $399.1m | 8,640,931 |  | Added +666,714 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $352.5m | 7,691,387 |  | Added +30,056 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $333.7m | 7,280,922 |  | Added +3,384 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $286.3m | 6,246,820 |  | Reduced −98,070 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $188.3m | 4,108,797 |  | Added +166,614 |
| [EARNEST PARTNERS LLC](/funds/1102578.md) | 2026-06-30 | $182.0m | 3,970,649 |  | Reduced −163,854 |
| [VICTORY CAPITAL MANAGEMENT INC](/funds/1040188.md) | 2026-06-30 | $135.1m | 2,947,138 |  | Reduced −172,781 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $104.4m | 2,289,566 |  | Reduced −85,123 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $78.3m | 1,707,953 |  | Added +59,177 |

## Recent filings

[All 1,575 filings](/companies/ubsi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 08:00 ET | [8-K](/filings/0001193125-26-428347.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-428347 |
| 2026-08-24 | 14:45 ET | [8-K](/filings/0001193125-26-363214.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-363214 |
| 2026-08-07 | 11:11 ET | [10-Q](/filings/0001193125-26-339565.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339565 |
| 2026-07-23 | 08:00 ET | [8-K](/filings/0001193125-26-313364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-313364 |
| 2026-05-18 | 12:01 ET | [8-K](/filings/0001193125-26-228386.md) | 5.07 Shareholder vote results | 0001193125-26-228386 |
| 2026-05-08 | 10:47 ET | [10-Q](/filings/0001193125-26-213783.md) | Quarterly report, period 2026-03-31 | 0001193125-26-213783 |
| 2026-04-23 | 08:01 ET | [8-K](/filings/0001193125-26-171886.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-171886 |
| 2026-04-01 | 08:00 ET | [DEF 14A](/filings/0001193125-26-135771.md) | Proxy statement, period 2026-05-13 | 0001193125-26-135771 |
| 2026-02-27 | 13:06 ET | [10-K](/filings/0001193125-26-081470.md) | Annual report, period 2025-12-31 | 0001193125-26-081470 |
| 2026-01-22 | 08:00 ET | [8-K](/filings/0001193125-26-018696.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-018696 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-081470.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 729986
- Tickers: UBSI
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: WV
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 11:52 ET. No prices; not investment advice.